106
Views
16
CrossRef citations to date
0
Altmetric
Review

Optimal management of thymic malignancies: current perspectives

, , , &
Pages 6803-6814 | Published online: 22 Jul 2019

Figures & data

Table 1 Masaoka-Koga staging

Table 2 The IASLC/ITMIG thymic epithelial tumors staging

Table 3 Stage grouping according to the IASLC/ITMIG thymic epithelial tumors staging

Figure 1 HES (Hematoxillin-Eosin-Safran) colorations of different subsets of thymic epithelial tumors, classified according to the World Health Organization classification.

Figure 1 HES (Hematoxillin-Eosin-Safran) colorations of different subsets of thymic epithelial tumors, classified according to the World Health Organization classification.

Figure 2 RYTHMIC recommendation for resectable thymic tumors from the RYTHMIC network, TNM I–II, Masaoka-Koga I–III.

Figure 2 RYTHMIC recommendation for resectable thymic tumors from the RYTHMIC network, TNM I–II, Masaoka-Koga I–III.

Figure 3 RYTHMIC recommendation for initially unresectable thymic tumors from the RYTHMIC network, TNM IIIa–IIIb and IVa, Masaoka-Koga III–IVa.

Figure 3 RYTHMIC recommendation for initially unresectable thymic tumors from the RYTHMIC network, TNM IIIa–IIIb and IVa, Masaoka-Koga III–IVa.

Figure 4 RYTHMIC recommendation for metastatic disease TNM IVb and Masaoka-Koga IVb.

Figure 4 RYTHMIC recommendation for metastatic disease TNM IVb and Masaoka-Koga IVb.

Figure 5 Operating views of thymic surgery: (A) enlarged thymectomy for B2 thymoma, the black arrow indicates the tumor developed in the left side of the thymus with mediastinal pleural involvement. (B) Right pleura after cytoreductive pleural surgery during ITCH procedure. The white arrow indicates pleural node of a A thymoma R0 resected two years before.

Figure 5 Operating views of thymic surgery: (A) enlarged thymectomy for B2 thymoma, the black arrow indicates the tumor developed in the left side of the thymus with mediastinal pleural involvement. (B) Right pleura after cytoreductive pleural surgery during ITCH procedure. The white arrow indicates pleural node of a A thymoma R0 resected two years before.

Figure 6 Chemotherapy and other treatments delivered in patients prospectively included in the French RYTHMIC registry.

Abbreviations: CAP, Cyclophosphamid-Adriblastin-Cisplatin; TKI, Tyrosin Kinase Inhibitors.

Figure 6 Chemotherapy and other treatments delivered in patients prospectively included in the French RYTHMIC registry.Abbreviations: CAP, Cyclophosphamid-Adriblastin-Cisplatin; TKI, Tyrosin Kinase Inhibitors.